Trials / Conditions / Melanoma Recurrent
Melanoma Recurrent
5 registered clinical trials studyying Melanoma Recurrent.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Different Doses of BI-1607 in Combination With Pembrolizumab and Ipilimumab, in Participants With Unresectable NCT06784648 | BioInvent International AB | Phase 1 / Phase 2 |
| Active Not Recruiting | Optimization of Immunotherapy Treatment for Advanced Melanoma in the Context of the Public Brazilian Health Sy NCT07376317 | Instituto do Cancer do Estado de São Paulo | Phase 2 |
| Active Not Recruiting | A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors NCT04478279 | Sapience Therapeutics | Phase 1 / Phase 2 |
| Completed | Pilot Study of Vigil™ + Pembrolizumab for Advanced Melanoma NCT02574533 | Gradalis, Inc. | Phase 1 |
| No Longer Available | Expanded Access for Pembrolizumab (MK-3475) NCT03311542 | Center Trials & Treatment | — |